Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors

Name: Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors
Published: 2010
License: Public Domain

Centre Leon Berard · 2010

ClinicalTrials.gov · Datasets · License: Public Domain · 2010

Open Source ↗

metastatic renal cell carcinoma, advanced refractory solid tumors histologically or cytologically confirmed, advanced solid tumors, dose escalation, association pazopanib-bevacizumab, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors

Related documents